Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Pharmacol Biochem Behav ; 82(4): 695-703, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16386786

RESUMO

There is evidence that local peripheral administration of morphine produces antinociception through the activation of the nitric oxide (NO)-cyclic GMP-K(+) channels pathway. Therefore we evaluated the possible participation of this pathway in the antinociceptive action produced by codeine in the rat 5% formalin test. Local peripheral injection of codeine produced a dose-dependent antinociception during the first and second phases of the test. Local pretreatment of the paws with the NO synthase inhibitor N(G)-L-nitro-arginine methyl ester (L-NAME), the soluble guanylyl cyclase inhibitor methylene blue, the ATP-sensitive K(+) channel inhibitors glibenclamide and tolbutamide, the non-selective voltage-gated K(+) channel inhibitors 4-aminopyridine (4-AP) and tetraethylammonium (TEA) and the opioid receptor blocker naloxone prevented codeine-induced antinociception in both phases of the test. L-NAME, methylene blue, K(+) channel blockers and naloxone by themselves did not modify formalin-induced nociceptive behavior. Our data suggest that codeine could activate the opioid receptor-NO-cyclic GMP-K(+) channels pathway in order to produce its peripheral antinociceptive effect in the formalin test.


Assuntos
Analgésicos Opioides/farmacologia , Codeína/farmacologia , GMP Cíclico/metabolismo , Óxido Nítrico/metabolismo , Canais de Potássio/metabolismo , Receptores Opioides/metabolismo , 4-Aminopiridina/farmacologia , Animais , Feminino , Glibureto/farmacologia , Azul de Metileno/farmacologia , NG-Nitroarginina Metil Éster/farmacologia , Naloxona/farmacologia , Ratos , Ratos Wistar , Tetraetilamônio/farmacologia , Tolbutamida/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA